CYP cynata therapeutics limited

9.68%

17.0¢

Ann: Conference Data Demonstrating Consistency of Cynata MSCs, page-20

First 20 Last

Share
Profile

Follow
Rossi70

4,419 Posts.

1573

17/11/22

16:49

Post #: 64837852
Share

Originally posted by Bazsa: ↑

"More Predictable"

Thats a intersting comment.

So why is there no undisputable data , after all if the cells were predictable it should be easy to prove benifit. But no clinical benifit has been shown after 150 patients been treated. That would indicate ether the cells do not work or they do but only in a very small population that remain unknown.

DFU The only conclution one can make is that the cells seem safe , I would be surprised if the DSMB were tasked to look at efficacy.

I was surprised at the progress made with the OA trial however if it is allowed to run its full length resaults will remain unknown till mid 26- 27. The half way point is now very close and this could triger a review by the DSMB. The recomendation to continue as planed would be a very big relief to the market as the outcome is at a pivotal point. But what if they stoped the trial? A single didget SP while investors hope for a more positive outcome for DFU.

Expand

Hi Bazsa,

If you are after Further information, about how good CYP cells are, then the only advice I can give you, is just give Fuji Film a call.

In relation to the O.A. trial, then why are CYP conducting currently a Phase 3 trial and not a Phase 1 trial.

IMHO.

Regards

Rossi70

CYP Price at posting: 35.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 20 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.015(9.68%)		Mkt cap ! $38.41M

Open	High	Low	Value	Volume
15.5¢	17.0¢	15.5¢	$47.10K	289.1K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	23813	3

View Market Depth

No.	Vol.	Price($)
1	50000	0.165
4	47240	0.155
4	161673	0.150
1	5000	0.145
2	45000	0.140

Price($)	Vol.	No.
0.170	18813	2
0.175	55250	1
0.180	62619	3
0.185	35990	1
0.195	19300	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

CYP (ASX) Chart

Ann: Conference Data Demonstrating Consistency of Cynata MSCs, page-20

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Conference Data Demonstrating Consistency of Cynata MSCs, page-20

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News